100 + INNOVATIONS
Structural Biology Facility( SBF)
Unlocking new frontiers in biotechnology and medical science with biomolecular AI tools and experimental methods
Learn More
Research Facility
Challenge
Designing drugs and treatments requires 3D macromolecule structures, but traditional methods are slow, costly and inaccessible. Faster AI-powered tools are urgently needed, as identified in the national Computational Structural Biology Roadmap. AI-powered tools have opened new options in protein design, accelerating therapeutic, diagnostic and biotechnology at an unprecedented scale.
Solution
Building on science recognised by the 2024 Nobel Prize, the SBF is transforming how humanity understands and designs biology. By integrating AI tools such as AlphaFold, GPU-powered computation and experimental data, the SBF makes worldleading biomolecular technologies accessible.
It accelerates the development of therapies, diagnostics and biotechnology, while reducing barriers to access. Through training, open collaboration and user partnerships, it is strengthening Australia’ s sovereign capability and unlocking innovations that benefit research, industry and the community.
Target customers / end-users
• academic and clinical researchers in molecular and structural biosciences
• biotechnology and pharmaceutical industry companies developing therapies and diagnostics
• government and health agencies seeking translational insights.
Progress
• named in the Accelerating Australia’ s AI Agenda Report( Business Council Australia)
• co-led the Australian Computational Structural Biology Roadmap
• collaborated in 38 projects, partner in AU $ 7.4m of competitive grants( MRFF, NHMRC).
42 active collaborations
124 researchers
Innovative research translation
Healthy Living
Computational methods in biology have seen rapid global growth, recognised by the 2024 Nobel Prize for advancing computational protein design and structure prediction. The Structural Biology Facility( SBF) builds on these breakthroughs by combining deep learning, biophysics and experimental integration to accelerate therapeutic development, precision medicine and biotechnology innovation across research and industry. • 99